• 四川大學(xué)華西醫(yī)院胃腸外科中心（四川成都 610041）;

引用本文： 周總光,王存. 細節(jié)決定成?。宏P(guān)注直腸癌根治術(shù)的基本問題. 中國普外基礎(chǔ)與臨床雜志, 2012, 19(6): 573-576. doi: 復(fù)制

1. Glimelius B， Påhlman L， Cervantes A， et al. Rectal cancer：ESMO Clinical Practice Guidelines for diagnosis， treatment and follow-up [J]. Ann Oncol， 2010， 21 Suppl 5：v82-v86.
2. 梁鴻， 裘正軍. 腹腔鏡下結(jié)直腸癌根治術(shù)的現(xiàn)狀和研究進展[J]. 現(xiàn)代腫瘤醫(yī)學(xué)， 2009， 17(8)：1575-1578.
3. Barbas AS， Turley RS， Mantyh CR， et al. Effect of surgeon specialization on long-term survival following colon cancer resection at an NCI-designated cancer center [J]. J Surg Oncol， 2011，doi：10. 1002/jso. 22154. [ Epub ahead of print].
4. Wiggers T， Jeekel J， Arends JW， et al. No-touch isolation technique in colon cancer：a controlled prospective trial [J]. Br J Surg， 1988， 75(5)：409-415.
5. Wang C， Zhou ZG， Wang Z， et al. Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum [J].Langenbecks Arch Surg， 2005， 390(4)：312-318.
6. Nagtegaal ID， Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? [J]. J Clin Oncol，2008， 26(2)：303-312.
7. Aly EH. Laparoscopic colorectal surgery：summary of the current evidence [J]. Ann R Coll Surg Engl， 2009， 91(7)：541-544.
8. Wasserberg N， Gutman H. Resection margins in modern rectal cancer surgery [J]. J Surg Oncol， 2008， 98(8)：611-615.
9. National comprehensive cancer network. NCCN guidelines version 3. 2012， rectal cancer[ J/OL]. http：//www. nccn. org/professionals/physician_gls/f_guidelines. aspsite.
10. Fujita S， Yamamoto S， Akasu T， et al. Lateral pelvic lymph node dissection for advanced lower rectal cancer [J]. Br J Surg，2003， 90(12)：1580-1585.
11. Yano H， Moran BJ. The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West [J]. Br J Surg， 2008， 95(1)：33-49.
12. Kim JC， Takahashi K， Yu CS， et al. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer [J]. Ann Surg， 2007， 246(5)：754-762.
13. Ergina PL， Cook JA， Blazeby JM， et al. Challenges in evaluating surgical innovation [J]. Lancet， 2009， 374(9695)：1097-1104.
14. Nagawa H， Muto T， Sunouchi K， et al. Randomized， controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy [J].Dis Colon Re ctum， 2001， 44(9)：1274-1280.
15. Kapiteijn E， Marijnen CA， Nagtegaal ID， et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer [J]. N Engl J Med， 2001， 345(9)：638-646.
16. Wang C， Zhou ZG， Yu YY， et al. Patterns of lateral pelvic lymph node metastases and micrometastases for patients with lower rectal cancer [J]. Eur J Surg Oncol， 2007， 33(4)：463-467.
  1. 1. Glimelius B， Påhlman L， Cervantes A， et al. Rectal cancer：ESMO Clinical Practice Guidelines for diagnosis， treatment and follow-up [J]. Ann Oncol， 2010， 21 Suppl 5：v82-v86.
  2. 2. 梁鴻， 裘正軍. 腹腔鏡下結(jié)直腸癌根治術(shù)的現(xiàn)狀和研究進展[J]. 現(xiàn)代腫瘤醫(yī)學(xué)， 2009， 17(8)：1575-1578.
  3. 3. Barbas AS， Turley RS， Mantyh CR， et al. Effect of surgeon specialization on long-term survival following colon cancer resection at an NCI-designated cancer center [J]. J Surg Oncol， 2011，doi：10. 1002/jso. 22154. [ Epub ahead of print].
  4. 4. Wiggers T， Jeekel J， Arends JW， et al. No-touch isolation technique in colon cancer：a controlled prospective trial [J]. Br J Surg， 1988， 75(5)：409-415.
  5. 5. Wang C， Zhou ZG， Wang Z， et al. Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum [J].Langenbecks Arch Surg， 2005， 390(4)：312-318.
  6. 6. Nagtegaal ID， Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? [J]. J Clin Oncol，2008， 26(2)：303-312.
  7. 7. Aly EH. Laparoscopic colorectal surgery：summary of the current evidence [J]. Ann R Coll Surg Engl， 2009， 91(7)：541-544.
  8. 8. Wasserberg N， Gutman H. Resection margins in modern rectal cancer surgery [J]. J Surg Oncol， 2008， 98(8)：611-615.
  9. 9. National comprehensive cancer network. NCCN guidelines version 3. 2012， rectal cancer[ J/OL]. http：//www. nccn. org/professionals/physician_gls/f_guidelines. aspsite.
  10. 10. Fujita S， Yamamoto S， Akasu T， et al. Lateral pelvic lymph node dissection for advanced lower rectal cancer [J]. Br J Surg，2003， 90(12)：1580-1585.
  11. 11. Yano H， Moran BJ. The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West [J]. Br J Surg， 2008， 95(1)：33-49.
  12. 12. Kim JC， Takahashi K， Yu CS， et al. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer [J]. Ann Surg， 2007， 246(5)：754-762.
  13. 13. Ergina PL， Cook JA， Blazeby JM， et al. Challenges in evaluating surgical innovation [J]. Lancet， 2009， 374(9695)：1097-1104.
  14. 14. Nagawa H， Muto T， Sunouchi K， et al. Randomized， controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy [J].Dis Colon Re ctum， 2001， 44(9)：1274-1280.
  15. 15. Kapiteijn E， Marijnen CA， Nagtegaal ID， et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer [J]. N Engl J Med， 2001， 345(9)：638-646.
  16. 16. Wang C， Zhou ZG， Yu YY， et al. Patterns of lateral pelvic lymph node metastases and micrometastases for patients with lower rectal cancer [J]. Eur J Surg Oncol， 2007， 33(4)：463-467.